3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
27
Lymphoid
6
Thoracic
3
Genitourinary
3
Dermatologic
3
Classical hematology
3
Plasma cell
2
Other hematologic neoplasm
2
Other
2
Head & Neck
2
Gynecologic
2
Breast
2
Other solid neoplasm
1
CNS
1
Conditions
Brain Neoplasms
404
Glioma
260
Glioblastoma
204
Central Nervous System Neoplasms
92
Neoplasms
87
Neuroblastoma
82
Astrocytoma
72
Neurofibromatosis 1
55
Breast Neoplasms
52
Meningioma
51
Lung Neoplasms
42
Oligodendroglioma
39
Head and Neck Neoplasms
35
Medulloblastoma
33
Sarcoma
30
Leukemia
30
Spinal Cord Neoplasms
29
Paraganglioma
28
Lymphoma
28
Pheochromocytoma
27
Carcinoma, Non-Small-Cell Lung
27
Prostatic Neoplasms
24
Neuroma, Acoustic
24
Ependymoma
24
Melanoma
22
Recurrence
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Ovarian Neoplasms
20
Neoplasm Metastasis
19
Lymphoma, Non-Hodgkin
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Colitis, Ulcerative
×
CNS
×
Clear all
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled